Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesPredictors of complete pathological response after neoadjuvant systemic therapy for breast cancer
The American Journal of Surgery, 10/08/09
Tan MC et al. – Patients with ER–negative and PR–negative and HER2/neu–amplified breast cancer phenotypes are more likely to experience pCR to neoadjuvant therapy. Although pCR is more frequently observed following neoadjuvant chemotherapy, it is rare following neoadjuvant endocrine therapy.
Related Articles
Sinusal localization of nodal micrometastases is a prognostic factor in breast cancer
Annals of Oncology, 11/04/09
Relevance Score: 67%
Energy Intake and Risk of Postmenopausal Breast Cancer: An Expanded Analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort
Cancer Epidemiology, Biomarkers & Prevention, 10/23/09
Relevance Score: 67%
Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging
The American Journal of Surgery, 10/07/09
Relevance Score: 67%
The predictive value of incidental PET/CT findings suspicious for breast cancer in women with non-breast malignancies
The American Journal of Surgery, 10/06/09
Relevance Score: 67%
A case–control study of reproductive factors associated with subtypes of breast cancer in Northeast China
Medical Oncology, 10/01/09
Relevance Score: 67%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo
The American Journal of Surgery, 12/11/09
Method of Detection of Breast Cancer in Low-Income Women
Journal of Women's Health, 12/11/09
Private insurance is the strongest predictor of women receiving breast conservation surgery for breast cancer
The American Journal of Surgery, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor